CVN14
CVN14 has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest paper, Jan 29, 2026: “Discovery of Potent, Selective, and Brain-Penetrant Small Molecule CD38 Inhibitors”.
At a glance
The findings reach cells, none yet in people. 1 lab in 3 countries.
Cells: a single group. Worms or flies, mice and humans: nothing yet.
- 1 lab in 3 countries
- Funder: Cerevance
- 1 of 1 finding with company ties
- Animals1
What did studies of CVN14 find?
1Studies of CVN14 measured one outcome, CD38.
CD38
downin cells1
1 study
CD38
downin cells1
CVN14 inhibits CD38 in cells.
“culminating in the identification of CVN14, a potent, selective, and brain-penetrant tool molecule”
Cells
Discovery of Potent, Selective, and Brain-Penetrant Small Molecule CD38 Inhibitors
ACS medicinal chemistry letters
Latest
1 paper in 12 monthsACS Medicinal Chemistry Letters
Discovery of Potent, Selective, and Brain-Penetrant Small Molecule CD38 Inhibitors
Experiments in animalsInterventions